These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23566382)

  • 1. Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics.
    Yallapu MM; Ebeling MC; Jaggi M; Chauhan SC
    Curr Drug Metab; 2013 May; 14(4):504-15. PubMed ID: 23566382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin nanoformulations: Beneficial nanomedicine against cancer.
    Maleki Dizaj S; Alipour M; Dalir Abdolahinia E; Ahmadian E; Eftekhari A; Forouhandeh H; Rahbar Saadat Y; Sharifi S; Zununi Vahed S
    Phytother Res; 2022 Mar; 36(3):1156-1181. PubMed ID: 35129230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin nanomedicine: a road to cancer therapeutics.
    Yallapu MM; Jaggi M; Chauhan SC
    Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin nanoformulations: a future nanomedicine for cancer.
    Yallapu MM; Jaggi M; Chauhan SC
    Drug Discov Today; 2012 Jan; 17(1-2):71-80. PubMed ID: 21959306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Applications of Curcumin Nanoformulations.
    Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
    AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.
    Zhang Y; Li Z; Huang Y; Xu Y; Zou B
    Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of curcumin nanoformulations to target folic acid receptor in cancer: Recent trends and advances.
    Hussain A; Kumar A; Uttam V; Sharma U; Sak K; Saini RV; Saini AK; Haque S; Tuli HS; Jain A; Sethi G
    Environ Res; 2023 Sep; 233():116476. PubMed ID: 37348632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
    Hafez Ghoran S; Calcaterra A; Abbasi M; Taktaz F; Nieselt K; Babaei E
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment.
    Yallapu MM; Ebeling MC; Khan S; Sundram V; Chauhan N; Gupta BK; Puumala SE; Jaggi M; Chauhan SC
    Mol Cancer Ther; 2013 Aug; 12(8):1471-80. PubMed ID: 23704793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives.
    Sharifi S; Fathi N; Memar MY; Hosseiniyan Khatibi SM; Khalilov R; Negahdari R; Zununi Vahed S; Maleki Dizaj S
    Phytother Res; 2020 Aug; 34(8):1926-1946. PubMed ID: 32166813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin, its derivatives, and their nanoformulations: Revolutionizing cancer treatment.
    Ahmad I; Ahmad S; Ahmad A; Zughaibi TA; Alhosin M; Tabrez S
    Cell Biochem Funct; 2024 Jan; 42(1):e3911. PubMed ID: 38269517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Prospective of Curcumin-loaded Nanomedicine in Brain Cancer Therapy: An Overview of Recent Updates and Patented Nanoformulations.
    Verma R; Rao L; Nagpal D; Yadav M; Kumar M; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2024; 18(3):278-294. PubMed ID: 37904561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
    Liu J; Chen S; Lv L; Song L; Guo S; Huang S
    Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes.
    Yallapu MM; Ebeling MC; Chauhan N; Jaggi M; Chauhan SC
    Int J Nanomedicine; 2011; 6():2779-90. PubMed ID: 22128249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review of the therapeutic potential of curcumin nanoformulations.
    Khezri K; Saeedi M; Mohammadamini H; Zakaryaei AS
    Phytother Res; 2021 Oct; 35(10):5527-5563. PubMed ID: 34131980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin Nanoformulations for Colorectal Cancer: A Review.
    Wong KE; Ngai SC; Chan KG; Lee LH; Goh BH; Chuah LH
    Front Pharmacol; 2019; 10():152. PubMed ID: 30890933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin and its formulations: potential anti-cancer agents.
    Ji JL; Huang XF; Zhu HL
    Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Cancer using Curcumin Encapsulated Vesicular Drug Delivery Systems.
    Hardwick J; Taylor J; Mehta M; Satija S; Paudel KR; Hansbro PM; Chellappan DK; Bebawy M; Dua K
    Curr Pharm Des; 2021; 27(1):2-14. PubMed ID: 32723255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
    Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
    Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.